POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New IV drug shows promise for inflammatory conditions
Disease control CompletedThis study looked at how the body handles an IV form of secukinumab, a drug that targets inflammation, in 65 adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). The main goals were to measure drug levels in the blood and check for side effects. Results will he…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:31 UTC
-
New hope for PMR patients: steroid-free remission possible with rituximab?
Disease control CompletedThis study tested if the drug rituximab can help people with polymyalgia rheumatica (PMR) stop taking steroids earlier. PMR causes pain and stiffness, and steroids are the main treatment but have side effects. The trial included 114 newly diagnosed patients and compared rituximab…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New drug may help patients with painful muscle condition taper steroids
Disease control CompletedThis study tested a drug called secukinumab in 381 adults aged 50 and older with polymyalgia rheumatica (PMR), a condition causing muscle pain and stiffness. Participants received either secukinumab or a placebo, along with a gradual steroid taper over 24 weeks. The goal was to s…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:56 UTC